Literature DB >> 8971178

Hypomethylation of L1 LINE sequences prevailing in human urothelial carcinoma.

B Jürgens1, B J Schmitz-Dräger, W A Schulz.   

Abstract

Alterations of DNA methylation were investigated in 6 urothelial carcinoma cell lines and 13 tumor tissues. The methylation of L1 LINE sequences was diminished in all cell lines (by 26 +/- 5%; range, 11-49%) and in most tumors (by 21 +/- 5%; range, 0-60%) compared to normal bladder mucosa. Hypermethylation of the calcitonin gene CpG island was restricted to cell lines and was not found in primary tumors, suggesting it had arisen during culture. In single-cell clones of a urothelial carcinoma cell line, both hypomethylation of L1 sequences and hypermethylation of the calcitonin gene persisted, indicating that they coexist within one cell. DNA methyltransferase expression did not correlate with the methylation status of the cell lines, but rather with histone H3 expression. Accordingly, it was down-regulated in quiescent cells. Aberrant expression of DNA methyltransferase is therefore not likely the cause for altered methylation patterns in urothelial carcinoma. L1 LINE hypomethylation seems to prevail in urothelial carcinoma and in this tumor might be useful for diagnostic or prognostic purposes.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8971178

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  35 in total

1.  Reading TE leaves: new approaches to the identification of transposable element insertions.

Authors:  David A Ray; Mark A Batzer
Journal:  Genome Res       Date:  2011-06       Impact factor: 9.043

2.  LINE-1 ORF1 Protein Is Up-regulated by Reactive Oxygen Species and Associated with Bladder Urothelial Carcinoma Progression.

Authors:  Patcharawalai Whongsiri; Chaowat Pimratana; Udomsak Wijitsettakul; Depicha Jindatip; Anapat Sanpavat; Wolfgang A Schulz; Michèle J Hoffmann; Wolfgang Goering; Chanchai Boonla
Journal:  Cancer Genomics Proteomics       Date:  2018 Mar-Apr       Impact factor: 4.069

3.  Features of ovarian cancer in Lynch syndrome (Review).

Authors:  Kanako Nakamura; Kouji Banno; Megumi Yanokura; Miho Iida; Masataka Adachi; Kenta Masuda; Arisa Ueki; Yusuke Kobayashi; Hiroyuki Nomura; Akira Hirasawa; Eiichiro Tominaga; Daisuke Aoki
Journal:  Mol Clin Oncol       Date:  2014-08-20

Review 4.  DNA methylation of cancer genome.

Authors:  Hoi-Hung Cheung; Tin-Lap Lee; Owen M Rennert; Wai-Yee Chan
Journal:  Birth Defects Res C Embryo Today       Date:  2009-12

5.  Mobilizing diversity: transposable element insertions in genetic variation and disease.

Authors:  Kathryn A O'Donnell; Kathleen H Burns
Journal:  Mob DNA       Date:  2010-09-02

Review 6.  DNA methylation in hepatocellular carcinoma.

Authors:  Iris Tischoff; Andrea Tannapfe
Journal:  World J Gastroenterol       Date:  2008-03-21       Impact factor: 5.742

Review 7.  DNA methylation in gastric cancer, related to Helicobacter pylori and Epstein-Barr virus.

Authors:  Keisuke Matsusaka; Sayaka Funata; Masashi Fukayama; Atsushi Kaneda
Journal:  World J Gastroenterol       Date:  2014-04-14       Impact factor: 5.742

8.  Epigenetic control of mammalian LINE-1 retrotransposon by retinoblastoma proteins.

Authors:  Diego E Montoya-Durango; Yongqing Liu; Ivo Teneng; Ted Kalbfleisch; Mary E Lacy; Marlene C Steffen; Kenneth S Ramos
Journal:  Mutat Res       Date:  2009-03-09       Impact factor: 2.433

9.  Genomic DNA hypomethylation as a biomarker for bladder cancer susceptibility in the Spanish Bladder Cancer Study: a case-control study.

Authors:  Lee E Moore; Ruth M Pfeiffer; Cristina Poscablo; Francisco X Real; Manolis Kogevinas; Debra Silverman; Reina García-Closas; Stephen Chanock; Adonina Tardón; Consol Serra; Alfredo Carrato; Mustafa Dosemeci; Montserrat García-Closas; Manel Esteller; Mario Fraga; Nathaniel Rothman; Núria Malats
Journal:  Lancet Oncol       Date:  2008-03-12       Impact factor: 41.316

10.  Cause and consequences of genetic and epigenetic alterations in human cancer.

Authors:  B Sadikovic; K Al-Romaih; J A Squire; M Zielenska
Journal:  Curr Genomics       Date:  2008-09       Impact factor: 2.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.